Quality enhancement takes center stage at IPA’s 8th Advanced GMP Workshop

New Delhi: Strengthening its commitment to promoting good manufacturing practices, the Indian Pharmaceutical Alliance (IPA) recently organised the 8th Advanced Good Manufacturing Practices Workshop.

The Workshop took place virtually on 3-4 October 2023, with 20+ subject matter experts, industry leaders and global regulators from USFDA, MHRA, CDSCO.

Over the years, the main purpose of the workshop has consistently been to facilitate the sharing of knowledge and the development of capabilities among Indian pharmaceutical companies, enabling them to embrace globally acknowledged manufacturing practices. The 8th edition of the Advanced GMP workshop served as a forum where manufacturers, regulators, and subject matter experts came together to engage in meaningful discussions and deliberate on strategies for advancing Manufacturing and Quality Excellence within the pharmaceutical industry.

The two-day virtual workshop commenced with a welcome address by Mr. Sudarshan Jain, Secretary General, IPA. In his inaugural address, Mr. Nilesh Gupta, Managing Director, Lupin and Chair of Quality Committee, IPA, highlighted the importance of fostering a culture of quality by all stakeholders in the industry. During her keynote address, Ms. S Aparna, Secretary, Department of Pharmaceuticals, Government of India emphasized that quality must be the hallmark of every newcomer in the pharmaceutical industry. The inaugural session also featured an address by Dr Sarah McMullen, Country Director, USFDA – India Office, who highlighted the importance of building a culture of quality across the functions from senior leadership to operator level.

The event witnessed the active participation of more than 1,500 industry and academic professionals from around the world. They engaged in informative sessions covering a broad spectrum of topics, including Quality Culture, Data Integrity within the context of Quality, Capacity Building, Next-Generation Operations, and India’s journey toward quality leadership. Additionally, the workshop delved into the transformative potential of Generative AI in the pharmaceutical sector, offering insights into the future of quality practices. Moreover, the discussions at the 8th Advanced GMP Workshop not only deepened the understanding of crucial issues but also facilitated the sharing of best practices in key areas of Quality.

Sudarshan Jain, Secretary General, IPA, said, “Quality is paramount for the pharma industry. Good Manufacturing practices ensure regulatory compliance and foster stakeholder relationships. IPA is committed to sharing knowledge, embracing best practices, and encouraging collaboration – making India a global benchmark in quality.”